Scott Samuelson, MD, medical oncologist at Utah Cancer Specialists, discusses the comorbidities that may affect treatment decisions for patients with metastatic prostate cancer.
Scott Samuelson, MD
Advertisement
Articles by Scott Samuelson, MD
Scott Samuelson, MD, medical oncologist, Utah Cancer Specialists, on frontline treatment of patients with prostate cancer and subsequent sequencing.
Advertisement
Latest Updated Articles
Dr. Samuelson on Frontline Treatment and Subsequent Sequencing in Prostate CancerPublished: June 12th 2018 | Updated:
Dr. Samuelson on the Comorbidities that Affect Treatment Decisions in Prostate CancerPublished: August 8th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5